Cargando…
OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung
BACKGROUND: Systemic and chronic inflammatory conditions in patients with breast cancer have been associated with reduced patient survival and increased breast cancer aggressiveness. This paper characterizes the role of an inflammatory cytokine, oncostatin M (OSM), in the preintravasation aspects of...
Autores principales: | Tawara, Ken, Bolin, Celeste, Koncinsky, Jordan, Kadaba, Sujatha, Covert, Hunter, Sutherland, Caleb, Bond, Laura, Kronz, Joseph, Garbow, Joel R., Jorcyk, Cheryl L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001163/ https://www.ncbi.nlm.nih.gov/pubmed/29898744 http://dx.doi.org/10.1186/s13058-018-0971-5 |
Ejemplares similares
-
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
por: Tawara, Ken, et al.
Publicado: (2019) -
OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition
por: Covert, Hunter, et al.
Publicado: (2019) -
Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis
por: Bolin, Celeste, et al.
Publicado: (2012) -
The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation
por: Goyden, Jake, et al.
Publicado: (2015) -
The clinical relevance of OSM in inflammatory diseases: a comprehensive review
por: Wolf, Cody L., et al.
Publicado: (2023)